Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. University of Manchester, Manchester, United Kingdom



Survival: 21.2 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: United Kingdom
   
City/State/Province: Manchester
   
Hospital: University of Manchester
   
Journal: Link
   
Date: 11/2013

Description:
Patients:
This phase 2 study involved 36 previously treated cutaneous T-cell lymphoma patients. The median patient age was 65 years and 69.4% were male.

Treatment:
Patients were treated with the chemotherapy agents gemcitabine and bexarotene.

Toxicities:
There were two deaths reported due to infection and other unspecified treatment-related toxicity. Grade 4 fatigue, diarrhea, and kidney failure were also reported.

Results:
The median overall survival was 21.2 months.

Support:
The study drug (bexarotene) was provided by Cephalon Limited.

Correspondence: Dr. TM Illidge; email: tmi@manchester.ac.uk

E-mail to a Friend Email Physician More Information